Showing 981 - 1,000 results of 5,085 for search '"cardiovascular"', query time: 0.08s Refine Results
  1. 981
  2. 982
  3. 983
  4. 984
  5. 985
  6. 986
  7. 987
  8. 988
  9. 989
  10. 990
  11. 991
  12. 992
  13. 993
  14. 994
  15. 995
  16. 996

    Removal of Expression of Concern for ‘Lipid-lowering therapy in patients with coronary heart disease: an Italian real-life survey. Results from the Survey on Risk FactOrs and CardiovascuLar secondary prevention and drug strategieS (SOFOCLES) in Italy’ by The Monaldi Archives for Chest Disease Editors

    Published 2025-01-01
    “…Results from the Survey on Risk FactOrs and CardiovascuLar secondary prevention and drug strategieS (SOFOCLES) in Italy’ by Caterina Oriana Aragona et al., Monaldi Arch Chest Dis, 2024, Accepted Manuscript, https://doi.org/10.4081/monaldi.2024.2972 IF: 1.1 Q4 NA   The Editors and Publisher of the Monaldi Archives for Chest Disease are publishing this removal of expression of concern to inform readers that the investigation is complete and all earlier issues have been addressed. …”
    Get full text
    Article
  17. 997

    Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies by Rohan Khera, Yuan Lu, Harlan M Krumholz, Martijn J Schuemie, Ruijun Chen, George Hripcsak, Marc A Suchard, Patrick B Ryan, Anna Ostropolets

    Published 2022-06-01
    “…Using an active comparator, new-user cohort design, LEGEND-T2DM will execute all pairwise class-versus-class and drug-versus-drug comparisons in each data source, producing extensive study diagnostics that assess reliability and generalisability through cohort balance and equipoise to examine the relative risk of cardiovascular and safety outcomes. The primary cardiovascular outcomes include a composite of major adverse cardiovascular events and a series of safety outcomes. …”
    Get full text
    Article
  18. 998

    A Study to Inform the Design of a National Multicentre Randomised Controlled Trial to Evaluate If Reducing Serum Phosphate to Normal Levels Improves Clinical Outcomes including Mortality, Cardiovascular Events, Bone Pain, or Fracture in Patients on Dialysis by Ramya Bhargava, Philip A. Kalra, Paul Brenchley, Helen Hurst, Alastair Hutchison

    Published 2015-01-01
    “…Secondary endpoints: consent rate, drop-out rates, and cardiovascular events. Discussion. This study will inform design of a large definitive trial of the effect of phosphate on mortality and cardiovascular events in dialysis patients. …”
    Get full text
    Article
  19. 999
  20. 1000